Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations.

Holmes MV. et al, (2024), Eur J Prev Cardiol, 31, 1015 - 1025

bubbleHeatmap: an R package for visualization of nightingale health metabolomics datasets.

Boxall R. et al, (2023), Bioinform Adv, 3

Response to comment on "Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics".

Bovijn J. et al, (2021), Sci Transl Med, 13

Lifelong genetically lowered sclerostin and risk of cardiovascular disease

Bovijn J. et al, (2019)

Include forthcoming?